Victrix Investment Advisors
Source: SEC Form 13F · as of Mar 2026Victrix Investment Advisors holds 13 biotech & pharma companies tracked by BioSniper, totaling $24.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$24.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 25,717 | $6.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 21,568 | $5.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,766 | $3.7M |
| MRKMerck & Co., Inc. | 24,714 | $3.0M |
| ABBVAbbVie Inc. | 9,414 | $2.0M |
| LLYELI LILLY & Co | 1,322 | $1.2M |
| MCKMcKesson Corporation | 1,064 | $921K |
| CAHCardinal Health Inc. | 2,588 | $547K |
| AMGNAMGEN INC | 901 | $317K |
| DGXQuest Diagnostics Incorporated | 1,310 | $257K |
| ABTABBOTT LABORATORIES | 2,435 | $250K |
| GEHCGE HealthCare Technologies Inc. | 3,120 | $222K |
| TEVATeva Pharmaceutical Industries Limited | 7,169 | $216K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.